Pulmonary hypertension - Hemodynamic diagnosis and management

被引：28

作者：

Chatterjee, K

De Marco, T

Alpert, JS

机构：

[1] Univ Calif San Francisco, Chatterjee Ctr Cardiac Res, Sch Med, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Heart Failure & Pulm Hypertens Program, Sch Med, San Francisco, CA 94143 USA

[3] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 17期

关键词：

D O I：

10.1001/archinte.162.17.1925

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hemodynamic classification of pulmonary hypertension relates to the hemodynamic mechanisms of pulmonary arterial hypertension, such as abnormalities of pulmonary blood flow, pulmonary vascular resistance, and pulmonary venous pressures. The therapeutic approaches can be directed to the hemodynamic mechanisms of pulmonary hypertension.

引用

页码：1925 / 1933

页数：9

共 57 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L
Moride, Y
Brenot, F
Rich, S
Benichou, J
Kurz, X
Higenbottam, T
Oakley, C
Wouters, E
Aubier, M
Simonneau, G
Begaud, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
[2] Alcazar R, 1995, Rev Esp Cardiol, V48, P142
[3] ALPERT JS, 1988, CARDIOLOGY
[4] [Anonymous], 1980, Ann Intern Med, V93, P391
[5] ARCHER SL, 1999, CLIN CARDIOLOGY ELDE
[6] Long-term outcome after pulmonary thromboendarterectomy
Archibald, CJ
Auger, WR
Fedullo, PF
Channick, RN
Kerr, KM
Jamieson, SW
Kapelanski, DP
Watt, CN
Moser, KM
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) : 523 - 528
[7] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
Barst, RJ
Rubin, LJ
Long, WA
McGoon, MD
Rich, S
Badesch, DB
Groves, BM
Tapson, VF
Bourge, RC
Brundage, BH
Koerner, SK
Langleben, D
Keller, CA
Murali, S
Uretsky, BF
Clayton, LM
Jobsis, MM
Blackburn, SD
Shortino, D
Crow, JW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
[8] CHANG CHJ, 1962, AMER J ROENTGENOL RA, V87, P929
[9] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
Channick, RN
Simonneau, G
Sitbon, O
Robbins, IM
Frost, A
Tapson, VF
Badesch, DB
Roux, S
Rainisio, M
Bodin, F
Rubin, LJ
[J]. LANCET, 2001, 358 (9288) : 1119 - 1123
[10] The role of thrombosis in severe pulmonary hypertension
Chaouat, A
Weitzenblum, E
Higenbottam, T
[J]. EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (02) : 356 - 363

← 1 2 3 4 5 6 →